APA (7th ed.) Citation

Badia, X., Perez, P., Layola, M., Checa, D., Tutor, A., Álvarez, A., . . . Torregrosa, V. (2007). Impact of treatment with agalsidasebeta on health-related quality of life in patients with Fabry disease. Clinical Therapeutics, 29(SUPP), S31. https://doi.org/10.1016/S0149-2918(07)80153-6

Chicago Style (17th ed.) Citation

Badia, X., et al. "Impact of Treatment with Agalsidasebeta on Health-related Quality of Life in Patients with Fabry Disease." Clinical Therapeutics 29, no. SUPP (2007): S31. https://doi.org/10.1016/S0149-2918(07)80153-6.

MLA (9th ed.) Citation

Badia, X., et al. "Impact of Treatment with Agalsidasebeta on Health-related Quality of Life in Patients with Fabry Disease." Clinical Therapeutics, vol. 29, no. SUPP, 2007, p. S31, https://doi.org/10.1016/S0149-2918(07)80153-6.